February 2015

Letter from the Editor

February 1, 2015

The Evolution Revolution Over the past couple of years, PharmaVOICE has been reporting on the industry’s move from a pill-based model to one in which the customer, or patient, is at the center. We’ve heard from analysts and thought leaders why this shift — driven by myriad factors, such as the changing physician landscape, a […]

UpFront

February 1, 2015

Film to Shed Light on Neurological Condition       The film crew chats with Kirk J., a young stroke victim currently coping with PBA. Avanir Pharmaceuticals has begun production of The PBA Film Project, a documentary to provide an intimate look at six real people living with a little-known neurological condition called PseudoBulbar Affect […]

Innovator’s Corner

February 1, 2015

The Next-Generation Artificial Lung Patients with acute respiratory failure have a new treatment option beyond ventilation. ALung Technologies has developed a next-generation device that could minimize or even replace mechanical ventilation. It is a simple, minimally invasive device that could be a new standard in the treatment of respiratory failure and CO2 retention. Although not […]

The Network

February 1, 2015

Instagram Emerging as Pharma Friendly  Trending Now: Verified badges and a high number of disease state group users bring Instagram within pharma marketing reach. Instagram began offering verified badges for brands at the end of 2014. The badges are designed to make it easier for people to identify and follow the authentic brands they care […]

What’s New

February 1, 2015

Dohmen Life Science Services Acquires Siren Interactive Trending now: Holistic patient-service model complemented by rare disease expertise.   Dohmen Life Science Services, a provider of outsourced business services for biopharma and medtech innovators, has acquired Siren Interactive Corp., a rare disease relationship marketing company. The acquisition further expands Dohmen’s direct-to-patient service model, by helping life-sciences […]

Tools of the Trade

February 1, 2015

Veeva Brings User-Guided Detailing to the Cloud Trending Now: New remote detailing solution expands life-sciences companies’ multichannel capabilities for improved customer engagement. Veeva CRM CoBrowse is a new remote detailing solution that enables real-time, interactive engagement and collaboration with customers online. CoBrowse allows call center, medical affairs, and field sales teams to lead healthcare professionals […]

Pharma Trax

February 1, 2015

Top 30 Pharma Companies R&D Spending Increases Trending Now: The overall increase in R&D spending was partly due to drug makers advancing their pipeline programs into later-stage clinical trials. The world’s leading 30 pharmaceutical companies spent a combined $112 billion on research and development (R&D) in 2013, an increase of $723 million over the previous […]

On The Calendar

February 1, 2015

Coming Attractions PMRG’s 2015 Healthcare Marketing Researchers Connect (formerly the PMRG Annual National Conference) is focused on leveraging new, strategic insights, to optimize the impact of business decision making. The 2015 event content is focused on enhancing the roles of market researchers by using new data technologies and methodologies that can provide the deep insights […]

Talent Pool

February 1, 2015

Executive appointments and promotions in the healthcare industry Pharma Pool Dr. Julie Gerberding Merck Strengthens Executive Team Merck has named Julie Gerberding, M.D., as executive VP for strategic communications, global public policy and population health. In this newly created executive committee position, Dr. Gerberding, who most recently served as president of Merck Vaccines, is responsible […]

Last Word

February 1, 2015

Addressing the Needs of THOSE WITH RARE DISEASES Peter Saltonstall, President and CEO of the National Organization for Rare Disorders (NORD), talks about recent orphan drug approvals. PV: 2014 was a record year for orphan drug approvals. What are your predictions for the orphan drug space for 2015? Saltonstall: The FDA’s Center for Drug Evaluation […]

Re-Imagining the Future of the Life-sciences Industry

February 1, 2015

The pharmaceutical industry — after facing dramatic changes over the past 10 years or so — has more transformative changes ahead. With an increasingly restrictive physician landscape, an ever-changing payer market, and technological advances that are speeding processes and improving data collection that result in real-world data, the industry is set to reinvent itself into […]

Marketing in a Digital World

February 1, 2015

As consumer use of mobile — especially smartphones — reaches critical mass, a truly integrated digital strategy is not only necessary, but positions the channel as the central port of entry for the customer experience. Back in the dawn of mobile marketing, pharma companies often viewed mobile as an add-on to their other channels, however […]

A New Frontier: Bioelectronics Medicines

February 1, 2015

The nervous system is essentially the body’s electrical and communication system that wires together all the nerves and organs — starting at the brain and central cord and branching out to every other part of the body. Technological advances have led researchers to consider how the nervous system might be tapped to control organ function […]

Gen Y – Gen How

February 1, 2015

Whether you want to hire them or sell them a product, meeting the needs of ­Millennials requires new strategies.   As the newest generation of healthcare consumers and employment pool, the Gen Y population — all 77 million of them — want you to know something. They want to be happy, they want to be […]

Ireland: Set to Soar Again

February 1, 2015

The Irish pharmaceutical market has grown exponentially over the past 50 years thanks to a skilled talent pool, trusted environment, and good government incentives.   The Republic of Ireland, a country of about 4.7 million people, is a member of the European Union and today ranks as one of the wealthiest countries in the world […]

Innovation is Leading Cancer Research

February 1, 2015

Industry experts discuss the various avenues — immunotherapy, epigenetics, biomarkers, and other targeting technology — companies are taking to address cancer research. Great progress has been made in the fight against cancer. Advances in molecular and genomic research have unveiled complexities and changed the perception of cancer, which we now know is more than 200 […]

SHOWCASE FEATURE: Outsourcing: Outsourcing in a New Era

February 1, 2015

Companies continue to examine new ways to optimize operations and capitalize on efficiencies through partnerships. As the industry continues to move to a more patient-centric model, which encompasses all aspects of the continuum from R&D through commercialization, CROs and other service partners are redefining their outsourcing models — hybrid, strategic partnership, functional, etc. — as […]

A New and Better Commercial Model for Enhanced Value

February 1, 2015

By combining the expertise of a CRO with that of a contract commercial organization, an outsourced provider can help clients bring business strategy to science and scientific expertise to business. Those companies able to take strategic advantage of this new model will be better positioned to focus on their strengths, bolster innovation, build value, and […]

Dynamic Strategic Outsourcing and New Commercial Paradigms: Benefits of Changing The Fixed-to-variable Ratio

February 1, 2015

Biopharmaceutical companies’ commercial paradigms must respond to an ever-changing marketplace, with increasing demands from both payers and patients for better care, improved outcomes, more affordable therapies, and increased speed to market. In a recent interview, George Esgro, Vice President & Head, U.S. Commercial Sales, Quintiles, discussed how strategic outsourcing can help companies deliver the necessary […]

Pharmaceutical Call Centers Build Relationships and Improve Outcomes

February 1, 2015

As communication channels expand, field-based sales representatives will be pivotal in coordinating communications with HCPs to support educational needs and ensure value is delivered no matter which channel is used. Life-sciences companies have a significant need to build relationships with healthcare providers (HCPs), patients, and caregivers. Healthcare providers are under tremendous pressure to see as […]

FEEDBACK